Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands

Table 1

Tumor uptake of various liposomal constructs.

	Caelyx	CTT2-SL liposome
Targeted formulation	No	Yes
Concentration-targeted; formulation	—	0.2%
Analyte	Doxorubicin	Doxorubicin
Time point (hours)	6	6
Tumor uptake (% ID/gram)	8.1%	19.0%